Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1261-1270 of 1,421) with videos related to

Pageof 143
Sort By:
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|August 21, 2016
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysisKathleen N Moore, James J Java, Katrina N Slaughter, et al.
Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.
European Journal of Applied Physiology|August 30, 2018
Effect of 1-week betalain-rich beetroot concentrate supplementation on cycling performance and select physiological parametersPetey W Mumford, Wesley C Kephart, Matthew A Romero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 1, 2021
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repairM Saito, S N Moore-Lotridge, S Uppuganti, et al.
Targeted Oncology|June 6, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid TumorsTodd M Bauer, Kathleen N Moore, Janet S Rader, et al.
Blood|June 25, 2025
Plasminogen as a Ribonucleoprotein: Regulatory small RNA Cargo Modulates Fibrinolysis and InflammationDanielle L Michell, Clark Massick, Kaustubh S Koya, et al.
Gynecologic Oncology|March 13, 2021
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC)Megan E Buechel, Danielle Enserro, Robert A Burger, et al.
Gynecologic Oncology|December 21, 2021
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trialCarol Aghajanian, Elizabeth M Swisher, Aikou Okamoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2024
Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational studyNiamh Chapman, Senali Jayasinghe, Myles N Moore, et al.
Pageof 143

Showing results (1261-1270 of 1,421) with videos related to

Sort By:
Pageof 143
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|August 21, 2016
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysisKathleen N Moore, James J Java, Katrina N Slaughter, et al.
Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.
European Journal of Applied Physiology|August 30, 2018
Effect of 1-week betalain-rich beetroot concentrate supplementation on cycling performance and select physiological parametersPetey W Mumford, Wesley C Kephart, Matthew A Romero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 1, 2021
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repairM Saito, S N Moore-Lotridge, S Uppuganti, et al.
Targeted Oncology|June 6, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid TumorsTodd M Bauer, Kathleen N Moore, Janet S Rader, et al.
Blood|June 25, 2025
Plasminogen as a Ribonucleoprotein: Regulatory small RNA Cargo Modulates Fibrinolysis and InflammationDanielle L Michell, Clark Massick, Kaustubh S Koya, et al.
Gynecologic Oncology|March 13, 2021
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC)Megan E Buechel, Danielle Enserro, Robert A Burger, et al.
Gynecologic Oncology|December 21, 2021
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trialCarol Aghajanian, Elizabeth M Swisher, Aikou Okamoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2024
Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational studyNiamh Chapman, Senali Jayasinghe, Myles N Moore, et al.
Pageof 143